Cancer Research

AI Predicts Meningioma Recurrence Using Routine Pathology
Tech & Innovation AI Predicts Meningioma Recurrence Using Routine Pathology

The subtle architecture of a brain tumor often conceals a lethal potential that remains invisible to even the most experienced human eyes during a standard microscopic examination. For patients diagnosed with meningioma, the most common primary brain tumor in adults, the journey following surgery

Can AI Predict Radiation Doses for Prostate Cancer?
Tech & Innovation Can AI Predict Radiation Doses for Prostate Cancer?

The field of nuclear medicine is currently witnessing a transformative shift as researchers leverage advanced artificial intelligence to solve the long-standing challenge of unpredictable radiation absorption in cancer patients. Recent breakthroughs led by Dr. Amit Nautiyal and a dedicated team of

Darlifarnib Shows High Efficacy in KRAS-Mutant Cancers
Research & Development Darlifarnib Shows High Efficacy in KRAS-Mutant Cancers

The persistent struggle against KRAS mutations has long been a defining battle in modern oncology, representing a target once thought to be totally unreachable by conventional drug design due to the protein's lack of accessible binding pockets. For decades, clinicians and researchers faced a

Can PSMA PET Detect Hidden Prostate Cancer Bone Metastases?
Tech & Innovation Can PSMA PET Detect Hidden Prostate Cancer Bone Metastases?

The silent migration of malignant cells toward the skeletal system remains the most significant threat to the long-term survival of patients diagnosed with high-risk prostate cancer. For decades, clinicians have operated under a significant diagnostic disadvantage, relying on structural imaging

Waypoint Bio Raises $20 Million for AI CAR-T Cell Therapies
Research & Development Waypoint Bio Raises $20 Million for AI CAR-T Cell Therapies

The biopharmaceutical industry reached a significant milestone this week as Waypoint Bio secured twenty million dollars in seed funding to accelerate the development of next-generation chimeric antigen receptor T-cell therapies that utilize advanced artificial intelligence models. This investment

Does Lifestyle Matter More Than Past Cancer Treatments?
Research & Development Does Lifestyle Matter More Than Past Cancer Treatments?

In the world of pediatric oncology, the narrative has long been dominated by the battle for survival. With childhood cancer survival rates in the United States and Europe now exceeding 85%, the victory is undeniable, yet it has birthed a new, complex challenge: the long-term health of over a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later